Androgenetic Alopecia Market Size, Share, Trends, Industry Forecast 2023-2033

Androgenetic alopecia represents a hair loss condition that largely affects the top and front of the scalp. It is distinguished by hair follicles that gradually decrease in size. This type of patterned loss of hair is commonly known as non-scarring follicle loss and has a particular pattern in both males and females. Androgenetic alopecia originates just above the temples and at the vertex area of the scalp in men. A border of hair remains at the sides and back of the head as it proceeds. This condition causes widespread thinning without hairline recession in females, as it does in males and seldom leads to overall hair loss. Men with androgenetic alopecia can be interpreted by their appearance, which includes symptoms and indications of male pattern baldness. In contrast, diagnosis in women typically entails a complicated sequence of testing. Additional tests can be performed using trichoscopy, and a biopsy may also be required to rule out other reasons for hair loss.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a free sample brochure: https://www.imarcgroup.com/androgenetic-alopecia-market/requestsample

Androgenetic Alopecia Market Trends and Drivers:

The escalating prevalence of severe follicle loss and damage, owing to unhealthy eating habits, sedentary lifestyles, and rising stress levels, is among the primary factors driving the androgenetic alopecia market. In addition, the increasing incidences of chronic diseases, such as hyperthyroidism, cancer, hypothyroidism, polycystic ovary disease (PCOD), lupus, hypopituitarism, etc., are further augmenting the market growth. Moreover, the growing popularity of low-level laser therapy, a non-pharmacological and non-surgical viable therapeutic procedure for hair restoration that offers the convenience of at-home use and minimizes the need for clinical visits, is also catalyzing the global market. Apart from this, the elevating requirement for off-label and over-the-counter medications and the high consumption of dietary supplements to prevent and control hair loss are expected to bolster the androgenetic alopecia market in the coming years.

Click here to view detailed information with table of content: https://www.imarcgroup.com/androgenetic-alopecia-market

Androgenetic Alopecia Market Report Segmentation:

The report has been segmented the market into following categories:

Time Period of the Study

• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the androgenetic alopecia market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the androgenetic alopecia market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current androgenetic alopecia marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Late-Stage Pipeline Drugs

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Regulatory status

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800